Insight Molecular Diagnostics(IMDX)
$1.78-0.08 (-4.30%)
IMDX
Insight Molecular Diagnostics hedge funds
$1.78
At close:-0.08 (-4.30%)
Want to see IMDX full AI Analyst Report?
Insight Molecular Diagnostics (IMDX) Hedge Fund Trading Activity
439 Followers
No recent Hedge Funds data found for IMDX
Hedge Fund Holdings in IMDX
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Reduced | -1.33% | $533,208 | <0.01% |
FAQ
Which hedge funds hold Insight Molecular Diagnostics?
Currently, no data Available
Are hedge funds buying or selling IMDX?
Currently, no data Available
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Insight Molecular Diagnostics stock?
Warren Buffet currently does not own shares in Insight Molecular Diagnostics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here

